Guanze Medical Information Industry (Holding) Co., Ltd., commonly referred to as Guanze Group, is a prominent player in the healthcare sector, headquartered in China. Established in 2001, the company has made significant strides in medical information services, focusing on areas such as healthcare data management, clinical research, and medical consulting. With a strong operational presence across various regions in Asia, Guanze Group is renowned for its innovative solutions that enhance healthcare delivery and patient outcomes. The company’s core offerings include advanced medical information systems and comprehensive data analytics, setting it apart in a competitive market. Recognised for its commitment to quality and excellence, Guanze Group has achieved notable milestones, solidifying its position as a trusted partner in the medical information industry.
How does Guanze Medical Information Industry (Holding) Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guanze Medical Information Industry (Holding) Co., Ltd.'s score of 15 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Guanze Medical Information Industry (Holding) Co., Ltd. reported an emissions intensity of approximately 0.0005 tonnes CO2e per unit of revenue, based on a revenue of about USD 25,678,826. This figure reflects emissions data that is not specifically categorised into Scope 1, 2, or 3, indicating a lack of detailed emissions reporting for these scopes. For 2021, the company reported a slightly higher emissions intensity of approximately 0.00037 tonnes CO2e per unit of revenue, with a revenue of about USD 33,226,709. This suggests a potential improvement in emissions efficiency relative to revenue generation. Currently, Guanze Medical does not have any publicly disclosed reduction targets or commitments under initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. The absence of specific reduction initiatives indicates that the company may still be in the early stages of developing a comprehensive climate strategy. Overall, while Guanze Medical has provided some emissions intensity data, further transparency and commitment to emissions reduction would enhance its climate accountability and align it with industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guanze Medical Information Industry (Holding) Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

